Intellia Therapeutics NTLA
NASDAQ NTLA
$12.26 +0.14 (+1.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) Depreciation and Depletion (2015 - 2017)

Updated

Intellia Therapeutics (NTLA) recorded Depreciation and Depletion of $3 million in FY2017, up 172.7% from $1.1 million in FY2016.

Analysis

Intellia Therapeutics (NTLA) Depreciation and Depletion (2015 - 2017) Analysis & Trends

Starting with FY2014, Intellia Therapeutics' Depreciation and Depletion history includes 4 years.

  • Annual Depreciation and Depletion has a three-year compound annual growth rate of 900.0% (FY2014 to FY2017).
  • Per Business Quant data, NTLA's Depreciation and Depletion was $1.1 million in FY2016 (+266.7%), $300,000 in FY2015 and $3,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Intellia Therapeutics 1.70 Bn 1.70 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 660,000.00
Dec 31, 2016 401,000.00
Sep 30, 2016 265,000.00
Jun 30, 2016 247,000.00
Mar 31, 2016 187,000.00
Dec 31, 2015 104,000.00
Sep 30, 2015 96,000.00
Jun 30, 2015 67,000.00
Mar 31, 2015 33,000.00
API Access

Intellia Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=NTLA&period=max&api_key=YOUR_API_KEY